The dispute between Medscheme and Bonitas Medical Fund could place up to 5 000 jobs at risk, according to Paul Hanratty, CEO of Sanlam. Sanlam owns Medscheme through its majority stake of 60 % in AfroCentric. While Hanratty described the conflict as financially manageable, he warned of severe human consequences if Medscheme loses its Bonitas contract, which accounts for about 40% of its revenue. – MedicalBrief (19 March 2026)
According to Discovery AI-driven health prompts are helping clients detect serious illnesses earlier, particularly cancer. – Business Day (18 March 2026)
India is set for a major shift as the patent on semaglutide—used in Ozempic and Wegovy by Novo Nordisk- expires on 20 March 2026. - BBC (19 March 2026)
SA’s National Health Laboratory Service (NHLS) reported a major disruption to TrakCare, its information system, leaving clinicians unable to access patient results and affecting care nationwide. – Daily Maverick (18 March 2026) The disruption also caused delays in specimen registration and testing disrupted clinical decisions, especially in emergencies. The incident revived concerns about system resilience following a 2024 cyberattack. The outage, linked to power failures at its Johannesburg headquarters, highlighted the absence of adequate backup systems. Authorities confirmed it was not a cybersecurity breach, and data integrity remains intact.